Central Trust Company’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Central Trust Company’s Portfolio HZNP Stock Details HZNP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-4,630	Closed	-$536K	–	1444
2023 Q3	$536K	Sell	4,630 -1,438	-24%	-$155K	0.02%	395
2023 Q2	$624K	Sell	6,068 -2,123	-26%	-$224K	0.02%	383
2023 Q1	$894K	Sell	8,191 -2,752	-25%	-$304K	0.03%	323
2022 Q4	$1.25M	Sell	10,943 -14,337	-57%	-$1.19M	0.04%	266
2022 Q3	$1.56M	Sell	25,280 -8,399	-25%	-$587K	0.05%	229
2022 Q2	$2.69M	Sell	33,679 -6,286	-16%	-$595K	0.09%	178
2022 Q1	$4.2M	Buy	39,965 +1,921	+5%	+$187K	0.12%	146
2021 Q4	$4.1M	Buy	38,044 +1,274	+3%	+$139K	0.12%	153
2021 Q3	$4.03M	Buy	36,770 +2,998	+9%	+$311K	0.14%	130
2021 Q2	$3.16M	Buy	33,772 +7,530	+29%	+$693K	0.11%	156
2021 Q1	$2.42M	Buy	26,242 +23,621	+901%	+$1.99M	0.09%	185
2020 Q4	$192K	Buy	2,621 +10	+0.4%	+$743	0.01%	483
2020 Q3	$203K	Sell	2,611 -1,850	-41%	-$127K	0.01%	448
2020 Q2	$248K	Buy	4,461 +4,205	+1,643%	+$180K	0.01%	411
2020 Q1	$8K	Buy	256 +20	+8%	+$677	﹤0.01%	907
2019 Q4	$9K	Sell	236 -30	-11%	-$920	﹤0.01%	969
2019 Q3	$7K	Buy	266 +230	+639%	+$5.95K	﹤0.01%	984
2019 Q2	$0	Sell	36 -312	-90%	-$7.91K	﹤0.01%	1204
2019 Q1	$9K	Sell	348 -72	-17%	-$1.71K	﹤0.01%	931
2018 Q4	$8K	Sell	420 -460	-52%	-$9.02K	﹤0.01%	962
2018 Q3	$17K	Buy	+880	New	+$16.7K	﹤0.01%	875
2017 Q3	–	Sell	-108	Closed	-$1K	–	1400
2017 Q2	$1K	Buy	+108	New	+$1.34K	﹤0.01%	1218

Other funds holding HZNP

IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return

BTI

Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return

VWA

Valued Wealth Advisors Holladay, Utah $247M AUM 21.93% 1-Year Est. Return

FSWA

Financial Synergies Wealth Advisors Houston, Texas $1.05B AUM 19.75% 1-Year Est. Return

BCMLT

Beacon Capital Management LLC (Tennessee) Franklin, Tennessee $567M AUM 16.01% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Central Trust Company's HZNP Position: Q4 2023 in Review

Central Trust Company sold out of Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) in Q4 2023, closing a stake of 4,630 shares — an estimated $536K sold.

Central Trust Company first reported a position in HZNP in Q2 2017 and held it in 22 quarters. The position peaked at $4.2M in Q1 2022. 6 funds tracked by Wall St. Rank hold HZNP as of Q4 2023.

Central Trust Company reported no remaining Horizon Therapeutics Public Limited Company Ordinary Shares position as of Q4 2023 after selling out during the quarter.
Central Trust Company sold 4,630 Horizon Therapeutics Public Limited Company Ordinary Shares shares in Q4 2023, an estimated $536K.
Central Trust Company first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q2 2017 and held it in 22 quarters.
Central Trust Company's Horizon Therapeutics Public Limited Company Ordinary Shares position peaked at $4.2M in Q1 2022.
6 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q4 2023.

Based on Central Trust Company's 13F filing for Q4 2023, filed 24 Jan 2024.